Read the full research summary on GHK-Cu Quality & Testing Every GHK-Cu batch is manufactured to exceed 99% purity and tested using HPLC and LC-MS protocols through an ISO 17025-accredited laboratory, confirming identity, potency, and batch-to-batch consistency
and would love to see more, join me on Youtube, Instagram , Facebook & Twitter
In the future, it will be essential to use selective MET inhibitors in combination with anti-PD-1/PD-L1 therapy, according to the specific molecules that are dysregulated by MET in different tumors
A rigorous 2026 UK review of HGF/c-Met dopaminergic neuroprotection, the fosgonimeton SHAPE Phase 2 PDD/DLB cognitive signal, the EJS ACT-PD platform trial, Read the full review Brain Aging & MCI 29 April 2026 Dihexa for MCI & Brain Aging: 2026 UK Cognitive Decline Review Can Dihexa help mild cognitive impairment (MCI) or brain aging
Chen 2008)
Continuous intrathecal recombinant human HGF injections exert functional recovery in non-human primate model of SCI (Aoki et al., 2019) and protect from neuronal death in ALS mice models (Ishigaki et al., 2007)